Szilárd Nemes1, Göran Garellick2, Roger Salomonsson3, Ola Rolfson2. 1. Swedish Hip Arthroplasty Register, Sweden Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden szilard.nemes@registercentrum.se. 2. Swedish Hip Arthroplasty Register, Sweden Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden. 3. Swedish Hip Arthroplasty Register, Sweden.
Abstract
AIMS: The EQ-5D questionnaire of EuroQol is an important tool, not only for researchers, but also for quality registers. Until 2013, Sweden did not have a country-specific value set to convert the EQ-5D health states into a single index. Commonly, the UK time trade-off (UK TTO) value set has been used. The study reported here aimed to establish an easy to use tool for the bidirectional crosswalk of the mean EQ-5D values based on two different value sets: the UK TTO and the Swedish TTO value sets. METHODS: Using an artificial data set encompassing all possible EQ-5D outcomes, we calculated the EQ-5D index using both the UK TTO and Swedish TTO value sets. Thereafter we modelled the relationship between the two indices using least-squares regression and major axis regression. A series of simulations was run to assess the feasibility of the obtained crosswalk algorithms. RESULTS: Major axis regression was superior to ordinary least-squares regression. Converting the mean EQ-5D values from the UK TTO scale to the Swedish TTO scale was more accurate than the inverse conversion. Values close to the floor and ceiling of the EQ-5D index were more challenging to crosswalk. CONCLUSIONS WE ESTABLISHED ALGORITHMS BASED ON MAJOR AXIS REGRESSION TO CROSSWALK EQ-5D VALUES BASED ON THE UK TTO AND THE SWEDISH TTO VALUE SETS THE PRESENTED ALGORITHM MAY FACILITATE COMPARISONS OF EQ-5D VALUES WHEN ONLY MEAN VALUES ARE AVAILABLE THE EXISTENCE OF A CROSSWALK ALGORITHM WILL EASE THE TRANSITION FROM THE UK TTO TO THE SWEDISH TTO VALUE SET.
AIMS: The EQ-5D questionnaire of EuroQol is an important tool, not only for researchers, but also for quality registers. Until 2013, Sweden did not have a country-specific value set to convert the EQ-5D health states into a single index. Commonly, the UK time trade-off (UK TTO) value set has been used. The study reported here aimed to establish an easy to use tool for the bidirectional crosswalk of the mean EQ-5D values based on two different value sets: the UK TTO and the Swedish TTO value sets. METHODS: Using an artificial data set encompassing all possible EQ-5D outcomes, we calculated the EQ-5D index using both the UK TTO and Swedish TTO value sets. Thereafter we modelled the relationship between the two indices using least-squares regression and major axis regression. A series of simulations was run to assess the feasibility of the obtained crosswalk algorithms. RESULTS: Major axis regression was superior to ordinary least-squares regression. Converting the mean EQ-5D values from the UK TTO scale to the Swedish TTO scale was more accurate than the inverse conversion. Values close to the floor and ceiling of the EQ-5D index were more challenging to crosswalk. CONCLUSIONS WE ESTABLISHED ALGORITHMS BASED ON MAJOR AXIS REGRESSION TO CROSSWALK EQ-5D VALUES BASED ON THE UK TTO AND THE SWEDISH TTO VALUE SETS THE PRESENTED ALGORITHM MAY FACILITATE COMPARISONS OF EQ-5D VALUES WHEN ONLY MEAN VALUES ARE AVAILABLE THE EXISTENCE OF A CROSSWALK ALGORITHM WILL EASE THE TRANSITION FROM THE UK TTO TO THE SWEDISH TTO VALUE SET.
Authors: Hassan M K Ghomrawi; Yuo-Yu Lee; Christina Herrero; Amethia Joseph; Douglas Padgett; Geoffrey Westrich; Michael Parks; Stephen Lyman Journal: Clin Orthop Relat Res Date: 2016-10-26 Impact factor: 4.176
Authors: Brandon Michael Henry; Waldemar Wrażeń; Leif Hynnekleiv; Michał Kłosiński; Przemysław A Pękała; Ewa Kucharska; Edward B Golec; Krzysztof A Tomaszewski; Maria Pąchalska Journal: Med Sci Monit Date: 2016-11-17
Authors: John A Ford; Andy P Jones; Geoff Wong; Garry Barton; Allan Clark; Erika Sims; Ann Marie Swart; Nick Steel Journal: Trials Date: 2019-04-04 Impact factor: 2.279